baber/WOPTO huggingface dataset:
Patent EP-0991727-A1 (EP)
Inventor: FLOSBACH CARMEN
IPC: C09D4/00
Filed: 1999-04-22
Abstract: This invention relates to radiation-curable coating compositions which containA) compounds having one or more free-radically polymerisable double bonds which additionally contain at least one further functional group reactive for the purposes of an addition and/or condensation reaction,B) compounds having one or more free-radically polymerisable double bonds, which additionally contain at least one further functional group reactive for the purposes of an addition and/or condensation reaction, wherein the additional reactive functional group is complementary to or reactive towards the additional reactive functional groups of component A),C) optionally at least one monomeric, oligomeric and/or polymeric compound having at least one functional group reactive towards the functional groups from component A) or component B)D) one or more photoinitiators as well asE) optionally solvents, water, pigments and/or extenders as well as conventional lacquer additives,wherein component A) and component B) differ from each other and component C) contains no free-radically polymerisable double bonds. The coating compositions are useful for the production of multilayer lacquer coatings, in particular automotive repair lacquer coating.
Patent EP-1071419-A1 (EP)
Inventor: HAMPSON AIDAN J
IPC: A61P25/28
Filed: 1999-04-21
Abstract: Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH3, and COCH3.
Patent EP-1075713-A1 (EP)
Inventor: LESESKY ALAN C
IPC: H01R31/06
Filed: 1999-04-30
Abstract: The modular connector includes a replaceable first cartridge having at least one communication terminal. The at least one communication terminal of the first cartridge can be electrically conductive and, in some instances, optically transmissive and has first and second opposed ends, wherein the first end is adapted to transmit a communication signal to a receptacle. The modular connector includes a second cartridge having at least one communication terminal defining first and second receptors. The at least one communication terminal of the second cartridge can be electrically conductive and, in some instances, optically transmissive. The first receptor of the at least one communication terminal of the second cartridge is adapted to receive a communication member, such as wire and, in some instances, an optical fiber. The second receptor of the at least one communication terminal of the second cartridge is adapted to releasably engage one end of the at least one communication terminal of the replaceable first cartridge. The first and second cartridges are adapted to be selectively mated and demated such that the first cartridge can be easily and efficiently replaced.
Patent EP-1077993-A1 (EP)
Inventor: GRIFFEY RICHARD
IPC: B01J19/00
Filed: 1999-05-12
Abstract: L'invention concerne un procédé de génération de bibliothèques virtuelles de composés, et l'utilisation de ces bibliothèques pour construire des bibliothèques combinatoires. Les composés virtuels sont générés in silico. L'invention concerne également des procédés de suivi de l'adjonction de fragments, de l'utilisation de réactifs, et des transformations réalisées. L'invention concerne, en outre, des procédés permettant d'établir une interface entre les informations nécessaires à la génération de bibliothèques de composés sans instruments, ces informations conduisant la synthèse effective des composés.
Patent EP-1008534-A1 (EP)
Inventor: HIGUCHI SHINTARO
IPC: G11B33/04
Filed: 1999-06-25
Abstract: A cartridge holder is shown which comprises a back portion
which has at an inner surface a plurality of cartridge gripping
parts by which one sides of cartridges are gripped, a pair of lid
portions which are pivotally connected to opposed sides of the
back portion through respective major hinge portions; catching
and caught portions which are provided at free ends of the lid
portions and lock the lid portions when the lid portions are
pivoted toward their closed position; and a plurality of extra
hinge portions which are defined by the back portion. 
     By roundly flexing the back portion at the major hinge
portions, the cartridge gripping parts, that is, the cartridges
gripped by these cartridge gripping parts are opened line a fan.
Thus, upper ends of the cartridges are separated thereby
facilitating handling of the upper ends of the cartridges by fingers
of a user. 
     In order to prevent a swell-out phenomenon of the back
portion which would occur when the back portion is roundly
flexed, there is provided a swell-out phenomenon suppressing
means. 
     In order to prevent removing of the cartridges from the
cartridge gripping parts which would occur when vibration and
shock are applied thereto under conveying of the holder, there is
provided a cartridge retaining rib.
Patent EP-1046132-A1 (EP)
Inventor: KNUDSEN NIELS V
IPC: G06T3/40
Filed: 1999-07-09
Abstract: The present invention relates to a method and a system for processing images. The invention relates in particular to a method and a system for processing an image using interpolating. The method determines a variation value for different sets of pixels in a CCD, and the set of pixels with the highest correlation (lowest numeric value) is selected. A missing colour at a given pixel is expressed in terms of the information contained in the selected set of pixels. If the variation value is below a certain threshold, due to noise or other factors, an alternative set of pixels using a different variation method may be selected. The missing colour is estimated as a weighted sum of e.g. the green samples divided by the weighted sum of e.g. the red samples multiplied by the sampled value from the pixel to be estimated.
Patent EP-1095131-A1 (EP)
Inventor: JUNG DIETER
IPC: C11D17/04
Filed: 1999-07-06
Abstract: Die vorliegende Erfindung beschäftigt sich mit einer portionierten Wasch- und Reinigungsmittelzusammensetzung in einem Beutel aus wasserlöslicher Folie, bei der mindestens 70 Gew.-% der Teilchen der Wasch- und Reinigungsmittelzusammensetzung Teilchengrößen oberhalb 800 νm aufweisen. Durch die Auswahl dieses Teilchengrößenbereiches werden üblicherweise auftretende herstellbedingte Probleme der Undichtigkeit der Beutelnähte und daraus resultierende Folgeprobleme vermieden.
Patent EP-1097440-A1 (EP)
Inventor: JONES DALE G
IPC: G08G1/095
Filed: 1999-07-13
Abstract: L'invention concerne un dispositif de signalisation routière muni d'une structure qui affiche des indications relatives à la circulation. On forme sur la structure au moins une diode DEL (45a-45h) conçue pour attirer l'attention aux indications. La ou les diodes DEL (45a-45h) possède(nt) une luminosité d'au moins 6000 millicandelas, de préférence entre environ 6000 et environ 60000 millicandelas.
Patent EP-1128834-A1 (EP)
Title: Combinaisons contre le diabete contenant une sulfonyluree, un glitazone et un biguanide
Inventor: WHITCOMB RANDALL W
IPC: A61K31/64
Filed: 1999-08-11
Abstract: Cette invention concerne des combinaisons d'un agent antidiabétique à base de glitazone, d'un agent antidiabétique à base de biguanide et, éventuellement, d'un agent antidiabétique à base de sulfonylurée. Ces combinaisons permettent de traiter le diabète et d'améliorer la régulation glycémique.
Patent EP-1110090-A1 (EP)
Inventor: KAUVAR LAWRENCE M
IPC: C12N15/09
Filed: 1999-08-30
Abstract: Particulate labels that can be individually identified comprise particulate supports to which are bound at least two distinguishable signal-generating moieties, such as fluorophores emitting at different wavelengths, which signals are detectable and measurable $(in situ). By varying the ratio and/or amounts of the signal-generating moieties, a multiplicity of different and distinguishable labels is obtained. Each different label can then be coupled to a different reagent and the individual interactions of each reagent with a target observed in parallel.
Patent EP-1121284-A1 (EP)
Inventor: LEBOISNE CEDRIC
IPC: B60T13/565
Filed: 1999-10-18
Abstract: A braking device having a flange (21) of master cylinder (2) secured to a pneumatic booster (1) by a nut (3) screwed onto a through-bolt (13) that extends through a front shell (111) and a rear shell (112). The through-bolt (13) has a threaded front end (131) and a shoulder (132) for holding a front wall (111) in alignment with the master cylinder (2). The nut (3) has a barrel engaged in a hole (211) in the flange (21) and is screwed onto the front end (131). A collar (32) on the nut (3) acts on the flange (21) to press the flange (21) against the front shell (111). The barrel (31) of the nut and shoulder (132) of the through-bolt (13) have first and second respective sections (S1, S2) which face each which engage the front shell (111) with the first section (S1) being larger than the second section (S2) such that the front shell (111) crumples on receipt of a impact force.
Patent EP-1117686-A1 (EP)
Title: Methods and materials for detection and measurement of free radical damage
Inventor: BAR-OR DAVID
IPC: G01N33/68
Filed: 1999-10-01
Abstract: The present invention teaches a marker useful for detection and measurement of free radical damage. Specifically, the invention takes advantage of alterations which occur to the N-terminus of the albumin molecule, a circulating protein in human blood, in the presence of free radicals. These alterations effect the ability of the N-terminus of the albumin molecule to bind metals. Methods for detecting and quantifying this alteration include evaluating and quantifying the cobalt binding capacity of an albumin-containing sample, analysis and measurement of the ability of albumin to bind exogenous cobalt, detection and measurement of the presence of copper in a purified albumin sample and use of an immunological assay specific to the altered form of serum albumin which occurs following free radical damage. Also taught by the present invention is the use of the peptide Asp Ala His Lys and the compound Asp-Ala-His-Lys-R, wherein R is any chemical group capable of producing a detectable signal when a metal ion capable of binding to the N-terminus of naturally-occurring albumin is bound to the compound, for detection and quantitation of the marker. Methods of the present invention also include use of the marker as a "biochemical tag", thereby allowing for sensitive detection and measurement of the efficacy of clinical drugs and therapeutics which result in the generation of free radicals or which act to limit free radical damage. The marker also acts as a "biological tag" of a process implicated in a wide array of diseases and conditions and, accordingly, may be used to monitor and assess such diseases and conditions. Finally, the invention provides antibodies, immunoassays, and kits for use in detecting or quantitating the marker.
Patent EP-1196354-A1 (EP)
Inventor: OLAOPA TOX
IPC: C02F3/30
Filed: 1999-12-06
Abstract: L'invention concerne un procédé de traitement des eaux usées qui consiste à extraire biologiquement l'azote et le phosphore. Ce procédé comporte au moins une étape impliquant l'utilisation d'une citerne ou d'un compartiment dimensionné et/ou adapté de façon à permettre l'obtention de conditions anoxiques ou anaérobies, et un bassin de régulation ou un épurateur primaire adapté.
Patent EP-1133627-A1 (EP)
Inventor: MAGRO LORENZO
IPC: F02F1/42
Filed: 1999-11-19
Abstract: La présente invention concerne un moteur à combustion interne comprenant, pour chaque cylindre, une pluralité de conduits d'admission (8a, 8b) pourvu chacun d'une partie d'entrée (9, 13) parallèle au plan de la tête des cylindres, et d'une partie de sortie (11, 15) s'ouvrant dans le cylindre (1) d'un siège de soupape d'admission (5, 7). Les conduits d'admission (8a, 8b) de chaque cylindre (1) comprennent un conduit principal (8a) permettant de produire dans le fluide un tourbillonnement coaxial à l'axe (A) du cylindre, et au moins un conduit de remplissage (8b) s'ouvrant dans le siège de soupape (7) en amont du conduit principal (8a), en rapport avec le sens de rotation du tourbillonnement. Par ailleurs, la partie de sortie (15) du conduit de remplissage (8b) est enroulée en spirale, alors que la partie d'entrée (13) comporte une section ouverte droite (13a) et une section guide arquée (13b). La résultante (R) du vecteur de vitesse du fluide traversant l'extrémité (16) de la partie d'entrée (13) est défléchie par rapport à l'axe (A) du cylindre, en fonction de la rotation du tourbillonnement du fluide dans le cylindre (1).
Patent EP-1151535-A1 (EP)
Inventor: ELLIOT SEBASTIAN
IPC: H03G3/20
Filed: 1999-12-16
Abstract: A device for ensuring that the amplitude of signals fall within a predetermined range, said device comprising input means (34) for receiving a plurality of input signals at substantially the same time, a first path for increasing the amplitude of any of the input signals having an amplitude below a first threshold, a second path for decreasing the amplitude of any of the input signals having an amplitude which exceeds a second threshold and combining the outputs of the first and second paths (78) to provide a plurality of signals having amplitudes between said first and second thresholds.
Patent EP-1057188-A1 (EP)
Inventor: NAJI PETER K
IPC: H01L27/105
Filed: 1999-12-13
Abstract: L'invention porte sur une RAM magnétique (4) comportant un réseau mémoire et un réseau mémoire de référence (75). Le réseau mémoireomprend des cellules magnétiques (41, 42) de stockage d'informations disposées en rangées et en colonnes, tandis que le réseau mémoire de référence comprend des cellules de mémoire (70, 71) de référence stockant une information de référence dans une ligne de rangée. Une cellule de mémoire magnétique présente selon son état magnétique une résistance maximale (R+ΔR) ou une résistance minimale (R). Une cellule de mémoire de référence comprend une cellules de mémoire (70, 71) et un transistor (72, 73), montés en série et présentant une résistance de référence aux bornes de ces deux composants. Le transistor est commandé par une commande de ligne de rangée de référence de manière à ce que la résistance de référence (74) prenne une valeur moyenne entre la résistance maximale et la résistance minimale de la cellule de mémoire magnétique. Un courant binaire de ligne (lb) et un courant binaire de référence (lr) sont respectivement fournis à la cellule de mémoire magnétique et à la cellule de mémoire de référence. Les états magnétiques font alterner le courant binaire de ligne qui est comparé au courant binaire de référence pour produire un signal de sortie.
Patent EP-1102588-A1 (EP)
Inventor: BENCHERIF MEROUANE
IPC: A61P25/28
Filed: 1999-06-02
Abstract: A pharmaceutical composition comprising a pharmaceutically effective amount of at least two components, one of those components being a nicotinic agonist and one of those components being an acetylcholinesterase inhibitor, wherein the acetylcholinesterase inhibitor is donepezil.
Patent EP-1147401-A1 (EP)
Inventor: JOSEFSON MATS
IPC: C07C217/32
Filed: 1999-12-22
Abstract: L'invention porte sur un procédé de suivi d'une réaction chimique à caractère pharmaceutique comportant les étapes suivantes: (1) obtention consécutive d'échantillons des spectres de Raman d'une solution de constituant chimiques présente dans le bac de réaction en l'irradiant par un rayonnement quasi monochromatique puis en détectant le rayonnement diffusé; (2) traitement desdits échantillons par analyse MVDA (analyse de données à variables multiples), puis élaboration d'au moins une première composante liée à une variable latente indicatrice du progrès de la réaction, l'analyse MVDA étant indépendante de l'étalonnage si on utilise des mesures relatives à des objets de composition connue; et (3) détermination de l'étendue de la réaction chimique sur la base d'au moins ce premier composant principal et facultativement sur la base d'un ou plusieurs composants principaux obtenus à partir de réactions antérieures de même nature.
Patent EP-1139737-A1 (EP)
Inventor: SOULA GERARD G
IPC: A01N25/30
Filed: 1999-12-17
Abstract: On décrit une composition de traitement des plantes permettant d'appliquer une substance chimique exogène anionique telle qu'un glyphosate sur le feuillage d'une plante. La composition renferme, en plus de la substance chimique exogène, un ou plusieurs composés amine correspondant chacun à la formule (I) dans laquelle R1 représente un groupe hydrocarbyle comprenant de 6 à environ 22 atomes de carbone et au moins 30 % de tous les groupes R1 présents contiennent entre 14 et environ 22 atomes de carbone ; R2 et R3 représentant indépendamment des groupes hydrocarbyle C¿1-15?. Les composés amine de la formule (I) sont présents dans la composition suivant un rapport molaire respectivement à la substance chimique exogène compris entre environ 0,01 :1 et environ 0,8 :1. La substance chimique exogène et le ou les composés amine de formule (I) sont dissous ou dispersés dans un support liquide agronomiquement acceptable, qui est de préférence de l'eau. On décrit également une composition concentrée sous forme solide ou liquide qui, lors de sa dissolution ou de sa dispersion dans de l'eau, ou bien lors de sa dilution avec de l'eau, forme une composition de traitement pour les plantes selon l'invention. Les compositions de traitement pour les plantes selon la présente invention sont utiles pour susciter une activité biologique, par exemple, l'activité herbicide, dans une plante.
Patent EP-1143984-A1 (EP)
Title: Composition anti-inflammatoire a base d'oeuf et methode de traitement et de prevention de l'inflammation
Inventor: BECK LEE R
IPC: A61K35/54
Filed: 1999-12-28
Abstract: L'invention concerne une composition et une méthode de traitement et de prévention de l'inflammation en général. Ladite composition est un produit de l'oeuf, provenant d'un oiseau ayant été hyperimmunisé à l'aide d'un mélange immunogène. L'invention porte également sur une composition anti-inflammatoire ayant été partiellement purifiée, provenant d'un oeuf immunisé. La composition anti-inflammatoire partiellement purifiée, lorsqu'elle est administrée à un sujet animal, est efficace dans le traitement et la prévention de l'inflammation.
Patent FI-20170161-A1 (FI)
Inventor: NIEMI JOUKO
IPC: B02C19/06
Filed: 2017-11-24
Abstract: Menetelmä ominaisuuksiltaan ongelmallisten, kuten reagoivien, räjähdys- ja syttymisherkkien tai kosteudelle herkkien jauheiden työkaasun (9) avulla tapahtuvaan prosessointiin, jossa prosessoinnissa kiinteässä muodossa olevia jauheita mikronisoidaan ja/tai mikroluokitellaan tvökaasua (9) apuna käyttäen, jolloin menetelmässä. - valittua työkaasua (9) kierrätetään kiertopiinssä, sen poistuvuutta minimoidaanja tarvittaessa suoritetaan lisäys, - prosessin loppuosalla työkaasu (9) valmistellaan kierrätyskelpoiseksi suodattamalla siitä kiinteä jauhefaasi pois tarkoituksen mukaiseen asteeseen, - työkaasuksi (9) valitaan kaasu jostain seuraavista ryhmistä: reagoimattomat inertit kaasut, prosessissa kuivattava paineilma, prosessissa happiköyhäksi säädetty paineilma, prosessiin syötettävä happiköyhäksi säädetty paineilma,
Patent FI-20185540-A1 (FI)
Title: Door stopper
Inventor: ANTTONEN JARI
IPC: E06B7/36
Filed: 2018-06-15
Abstract: The door stopper (1) comprises a wedge element (2) having a first (2.1) and a second surface (2.2) arranged in parallel facing opposite directions, each surface having a height and a width, wherein the second surface (2.2) is configured to be engaged with the frame (7) or a hinge (8) of a door. At least one side surface (2.3) connects said surfaces and is configured to engage at least with a door leaf (9). The distance between the first and the second surface is smaller than the smallest dimension of the heights and widths of said surfaces. The second surface (2.2) is equipped with a magnet (4) such that the door stopper is attachable to a metal door frame or to a metal hinge. The shape of the first (2.1) and second surface (2.2) is round and a gripping element (3) has been attached to the first surface (2.1) which gripping element (3) protrudes outwardly from the first surface.
Patent HK-1023516-A1 (HK)
Title: Pharmaceutical composition containing stimulators of interferon-gamma
Inventor: FERGUSON MARK WILLIAM JAMES
IPC: A61P17/02
Filed: 2000-05-10
Abstract: The present invention provides compositions for promoting the healing of chronic wounds comprising stimulators of IFN- gamma .
Patent HK-1025092-A1 (HK)
Title: (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
Inventor: HEYKANTS JOZEF JAN PIETER
IPC: C07D211/58
Filed: 2000-07-08
Abstract: The present invention concerns (+)-norcisapride, and its pharmaceutically acceptable acid additions salts, a process for preparing said compound, and its use for the manufacture of a medicament for treating gastro-intestinal disorders while avoiding central nervous system effects. Also provided are method of treating gastro-intestinal disorders.
Patent HK-1028981-A1 (HK)
Title: Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
Inventor: MIZZEN LEE
IPC: A61K39/00
Filed: 2000-11-24
Abstract: This document describes compositions and methods for inducing an immune response (e.g., a cellular response such as a cell-mediated cytolytic immune response) to a human papillomavirus (HPV) antigen, which can be displayed by HPV or exhibited by infected cells (e.g., cells from cervical and other tumors). The HPV protein can be joined to a stress protein by chemical conjugation or noncovalently using linking moieties, or by fusion (e.g., a recombinant fusion protein). Also described are expression vectors containing sequences encoding HPV antigens and stress proteins, which can be introduced into cells of a subject or cells ex vivo. Also described are compositions that include a stress protein linked to an HPV antigen and another pharmacologically acceptable component and stress protein -HPV antigen fusions and conjugates. These compositions can be used to induce or enhance an immune response against HPV and cells that exhibit HPV antigens, including HPV-associated tumors.
Patent HK-1031322-A1 (HK)
Title: Treatment of stress and preconditioning against stress
Inventor: HAMET PAVEL
IPC: A61K41/00
Filed: 2000-12-28
Abstract: Symptoms of stress such as elevated blood pressure in mammals are treated, and mammalian bodies are preconditioned to manifest reduced adverse reactions to subsequently encountered stresses, by injecting into the mammalian patient a small quantity of the patient's own blood which has been previously extracted and subjected extracorporeally to at least one stressor, such as ultraviolet radiation, an oxidative environment, ozone-oxygen and mild heating, especially infra-red radiation causing mild heating. Particularly beneficial combinations of stressors are simultaneous applications of UV radiation and an ozone-oxygen gas mixture bubbled through the blood sample to provide the oxidative environment, or simultaneous application of UV radiation, ozone-oxygen gas mixtures and mild heating. One specific use of the invention is in preconditioning against ischemic-reperfusion injury, e.g. prior to surgery.